The Journal of Pain
Volume 10, Issue 6 , Pages 609-618, June 2009

Changes in Gray Matter Density in Fibromyalgia: Correlation With Dopamine Metabolism

  • Patrick B. Wood

      Affiliations

    • Departments of Family Medicine, Anesthesiology, and Psychiatry, Louisiana State University Health Sciences Center – Shreveport
    • Corresponding Author InformationAddress reprint requests to Dr Patrick B. Wood, Angler Biomedical Technologies, LLC, 18401 Reed Parks Road, Jonestown, TX 78645.
  • ,
  • Michael F. Glabus

      Affiliations

    • Laboratory of Biological Psychiatry, Department of Psychiatry, Louisiana State University Health Sciences Center – Shreveport
  • ,
  • Ryan Simpson

      Affiliations

    • Laboratory of Biological Psychiatry, Department of Psychiatry, Louisiana State University Health Sciences Center – Shreveport
  • ,
  • James C. Patterson 2nd

      Affiliations

    • Department of Psychiatry, Louisiana State University Health Sciences Center – Shreveport, PET Imaging Center, Biomedical Research Institute of Northwest Louisiana, Shreveport, Louisiana

Received 20 July 2008; received in revised form 17 November 2008; accepted 6 December 2008. published online 24 April 2009.

Abstract 

Fibromyalgia (FM) has been associated with alterations in brain morphometry and abnormal dopaminergic neurotransmission. Evidence from preclinical models has demonstrated that dopamine plays a role in promoting neuronal integrity. We therefore sought to confirm previous findings of reduced gray matter density in subjects with FM and to determine whether variations in dopamine metabolism might affect gray matter density. Voxel-based morphometry was used to evaluate anatomical magnetic resonance imaging data from 30 female FM subjects in comparison with 20 age- and gender-matched healthy control subjects. In addition, data from a subset of subjects from both groups who had previously participated in our positron emission tomography study using radiolabeled DOPA (n = 14; 6 FM subjects and 8 control subjects) was used to determine whether correlation might exist between gray matter density and dopamine metabolism. We found a significant reduction in gray matter density within the bilateral parahippocampal gyri, right posterior cingulate cortex, and left anterior cingulate cortex. In addition, a positive correlation was demonstrated between an index of dopamine metabolism from the ventral tegmental area wherein cell bodies of corticolimbic projection neurons originate and gray matter density, specifically in the bilateral parahippocampal gyri and left pregenual cortex. The current results confirm our previous findings that FM is associated with altered brain morphometry. Alterations in dopamine metabolism might contribute to the associated changes in gray matter density.

Perspective

Fibromyalgia is associated with reductions in gray matter density within brain regions ostensibly involved in phenomena related to the disorder, including enhanced pain perception, cognitive dysfunction, and abnormal stress reactivity. Given mounting evidence of abnormal dopaminergic neurotransmission associated with the disorder, the strong correlation between dopamine metabolism and gray matter density provides insight as to the pathophysiology that might contribute to these changes.

Key words: Cingulate cortex, dopamine, fibromyalgia, parahippocampal gyrus, pregenual cortex, voxel-based morphometry

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Supported in part by competitive grants from the American Fibromyalgia Syndrome Associations (AFSA), Inc. and the Biomedical Research Foundation of Northwest Louisiana.

PII: S1526-5900(09)00007-8

doi:10.1016/j.jpain.2008.12.008

The Journal of Pain
Volume 10, Issue 6 , Pages 609-618, June 2009